Nov 07, 2019
Signant Health Proud to Sponsor the Philadelphia Walk to End Alzheimer's in Nationwide Effort to Build Awareness, Raise Funds and Advance Research Towards a Cure
Nov 07, 2019
EIP Pharma Announces Clinical Trial Results of REVERSE-SD, a Phase 2b Study of Neflamapimod in Early-stage Alzheimer's Disease
Nov 07, 2019
Arkuda Therapeutics Closes $44M Series A Financing to Advance Novel Medicines Targeting Progranulin and Lysosomal Biology to Treat Neurodegenerative Diseases
Nov 05, 2019
ChemoBrain Co.(TM) Announces Launch of First-Ever Treatment for Cancer Survivors Suffering from the Cognitive Side Effects of Chemotherapy
Nov 04, 2019
Alzheimer's Association Doubles Investment to $60 Million for Part the Cloud Grant Program
Nov 02, 2019
Green Valley Announces NMPA Approval Of Oligomannate For Mild To Moderate Alzheimer's Disease
Oct 31, 2019
November is Alzheimer's Awareness Month-Here Are Four Things to Remember
Oct 29, 2019
Unique Alzheimer's Disease Tau Vaccine Shows Great Potential in Pre-Clinical Studies
Oct 29, 2019
Dementia expert offers senior care organizations discounted training certification as part of National Alzheimer's Disease Awareness Month
Oct 28, 2019
Meridian Senior Living Communities Recognize National Alzheimer's Disease Month
Oct 24, 2019
Fourth Annual AFTD Benefit Raises More Than $2 Million in Support of Frontotemporal Degeneration Research, Support and Awareness
Oct 14, 2019
Life Molecular Imaging and Positron Pharma announce a strategic partnership for manufacturing and distribution of PI-2620 in Chile
Oct 13, 2019
Fruit Street Telehealth Platform Selected for Clinical Trial to Reduce Cognitive Decline andDementia Risk
Oct 01, 2019
Campaign launched to improve quality of life for people with severe dementia
Sep 30, 2019
World Alzheimer's Month Addresses Stigma Associated with Alzheimer's and Dementia
Sep 25, 2019
Fit Minds' Cognitive Coaching Expands its Impact throughout Florida's Gulf Coast Region
Sep 19, 2019
Maria Shriver, The Women's Alzheimer's Movement, And Equinox Fitness Clubs Announce Move For Minds 2019
Sep 12, 2019
New Tech-Enabled Rehab Program Designed to Improve Recovery Experience for People Living with Dementia
Sep 11, 2019
AgeneBio Announces Additional Funding to Advance Novel GABA-A Therapeutic Program to Address Alzheimer's and Other CNS Conditions
Sep 09, 2019
Axon Announces Positive Results From Phase II ADAMANT Trial for AADvac1 in Alzheimer's Disease